Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Rhea-AI Summary

Medtronic (NYSE: MDT) announced that Chairman and CEO Geoff Martha will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 starting at 10:30 a.m. PST (12:30 p.m. CST). Martha will deliver a formal presentation and take questions, followed by a Q&A session with EVP and CFO Thierry Piéton.

A live webcast and an archive will be available the same day via the Events link on the company's investor relations website.

News Market Reaction – MDT

+3.03%

1 alert

+3.03% News Effect

On the day this news was published, MDT gained 3.03%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: January 12, 2026 Presentation time: 10:30 a.m. PST Employee count: 95,000+ people +3 more

6 metrics

Conference date January 12, 2026 J.P. Morgan healthcare conference presentation

Presentation time 10:30 a.m. PST Start of CEO presentation at conference

Employee count 95,000+ people Global Medtronic workforce

Countries served 150+ countries Geographic footprint

Health conditions 70 conditions Conditions treated by Medtronic technologies and therapies

Therapy impact rate 2 people every second Patients reached by Medtronic technologies

Market Reality Check

Price: $97.66 Vol: Volume 5,365,598 is sligh...

normal vol

$97.66 Last Close

Volume Volume 5,365,598 is slightly below the 20-day average 5,821,750 (relative volume 0.92x) ahead of the conference appearance. normal

Technical Shares at $97.36 are trading above the 200-day MA of $91.30, and about 8.44% below the 52-week high.

Peers on Argus

Key medical device peers show mixed but generally positive moves: SYK +1.07%, BS...

Key medical device peers show mixed but generally positive moves: SYK +1.07%, BSX +1.27%, ZBH +2.64%, PHG +1.63%, while EW -0.98%. MDT’s flat move of about -0.01% appears stock-specific rather than part of a broad sector swing.

Common Catalyst One peer, Stryker (SYK), also issued an earnings-related date announcement, suggesting a period of calendar and conference updates across large-cap medtech.

Historical Context

5 past events · Latest: Dec 19 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 19	IPO announcement	Neutral	-0.9%	Filed S-1 for proposed IPO of Diabetes business MiniMed on Nasdaq.
Dec 04	Dividend declaration	Positive	-0.6%	Declared <b>$0.71</b> per share Q3 FY26 dividend, extending Dividend Aristocrat streak.
Dec 03	FDA clearance	Positive	+0.0%	Received FDA clearance for Hugo robotic-assisted surgery system for urologic use.
Dec 02	Product launch	Positive	-1.3%	Began U.S. commercial launch of MiniMed 780G system with Instinct sensor.
Nov 18	Earnings results	Positive	+4.7%	Reported strong Q2 FY26 results and raised guidance, highlighting growth drivers.

Pattern Detected

Recent MDT news has often produced modest price reactions, with stronger movement around earnings and more mixed or negative reactions to otherwise positive product and dividend announcements.

Recent Company History

Over the last several months, Medtronic reported strong Q2 FY26 results with revenue of $8.96B and raised guidance, which saw a +4.69% move. It followed with U.S. launches and FDA clearance for key technologies like the Hugo and MiniMed 780G systems, which drew limited or slightly negative reactions. Corporate actions included a continued $0.71 quarterly dividend and an IPO filing for the Diabetes business, MiniMed. Today’s conference participation fits into this pattern of ongoing investor communication rather than a discrete financial or regulatory catalyst.

Market Pulse Summary

This announcement highlights Medtronic’s participation at a major healthcare conference, with the CE...

Analysis

This announcement highlights Medtronic’s participation at a major healthcare conference, with the CEO and CFO presenting and taking questions on January 12, 2026. It reinforces the company’s global scale, including 95,000+ employees across 150+ countries and technologies addressing 70 conditions. Investors may focus on how any commentary connects back to recent earnings, product launches, and the planned MiniMed IPO, as seen in prior disclosures.

Key Terms

forward-looking statements

1 terms

forward-looking statements regulatory

"Any forward-looking statements are subject to risks and uncertainties..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 10:30 a.m. PST (12:30 p.m. CST). Immediately following the presentation, Martha will be joined by evp and chief financial officer, Thierry Piéton, to answer questions on the company.

A live webcast of the presentation and Q&A session will be available on January 12, 2026, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the presentation and Q&A session will be available on the same webpage later in the day.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts
Erika Winkels
Public Relations
+1-612-558-8932

Ingrid Goldberg
Investor Relations
investor.realations@medtronic.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-chairman-and-ceo-geoff-martha-to-speak-at-jp-morgan-healthcare-conference-302653104.html

SOURCE Medtronic plc

FAQ

When will Medtronic (MDT) present at the J.P. Morgan Healthcare Conference in 2026?

Medtronic will present on January 12, 2026, beginning at 10:30 a.m. PST (12:30 p.m. CST).

Who from Medtronic (MDT) will speak and participate in the Q&A on January 12, 2026?

Chairman and CEO Geoff Martha will present and be joined for the Q&A by EVP and CFO Thierry Piéton.

How can investors watch Medtronic's (MDT) J.P. Morgan conference presentation on January 12, 2026?

A live webcast and same-day archive will be available via the Events link on Medtronic's investor relations website.

Will Medtronic (MDT) provide an archived replay of its January 12, 2026 presentation?

Yes. An archive of the presentation and Q&A will be posted later the same day on the investor relations Events webpage.

What topics will Medtronic (MDT) leadership address at the January 12, 2026 presentation?

Leadership will make a formal company presentation and answer investor questions during the presentation and Q&A session.

Where can I find more investor contact information for Medtronic (MDT)?

Investor relations contact details are provided by the company on its investor relations website and in the press release contacts section.